Skip to main content
Caplight Logo









Signios Biosciences

Signios Biosciences

Private
Foster City, CaliforniaHealthcare & Life Scienceshttps://signiosbio.com

Company Overview

Signios Biosciences operates in Healthcare & Life Sciences and is based in Foster City, California. It was founded in 2025.

Signios Biosciences is a biotechnology company that provides an integrated end-to-end suite of multiomic technologies and an AI-driven bioinformatics platform for pharmaceutical companies, biotech firms, and academic institutions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Signios Biosciences Comparables

Compare Signios Biosciences with similar companies based on industry and business-model similarity.

Signios Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Carolina Molecular
85%
Admera Health
84%
Psomagen, Inc.
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Signios Biosciences Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Signios Biosciences. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 6, 2026

    Monthly visitors increased 40% MoM.

  • Jul 17, 2025

    Grew 17% QoQ, from 18 to 21 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Signios Biosciences Filings

Explore SEC and related filing metadata, where available.

Signios Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Signios Biosciences's valuation, stock price, and market status.

Is Signios Biosciences a public or private company?

Signios Biosciences is a private company.

What is the current stock price of Signios Biosciences?

Signios Biosciences is a private company, so its shares have no public market price. Caplight tracks Signios Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Signios Biosciences worth (valuation)?

Valuation information for Signios Biosciences is not publicly available.

Can I buy Signios Biosciences stock?

Signios Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Signios Biosciences's last funding round?

Funding round information for Signios Biosciences is not publicly available.

Who are the main investors in Signios Biosciences?

Investor information for Signios Biosciences is not publicly disclosed.

Will Signios Biosciences IPO soon?

No public IPO plans have been announced for Signios Biosciences.

How can I track Signios Biosciences secondary market activity?

Caplight tracks bids, offers, and trades in Signios Biosciences's shares on secondary markets.

Firmographic Details

HeadquartersFoster City, California
Employee Range17
Year Founded2025
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?